AstraZeneca ((AZN +0.7%) gets a bump higher from a Jefferies upgrade to Buy, despite the...

|About: AstraZeneca Group plc (AZN)|By:, SA News Editor

AstraZeneca ((AZN +0.7%) gets a bump higher from a Jefferies upgrade to Buy, despite the company's weaK Q1 revenue results last week. The firm says market expectations are too high on the revenue side, noting the company's attractive dividend yield should be a positive catalyst for the shares.